ERIKA GEORGE: Open Payments
NPI 1114467677 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,401 in 66 payments from 19 companies in 2025. Trend: 2023 $1,430 · 2024 $1,463 · 2025 $1,401
Food & beverage: $1,401
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $257 |
| Novo Nordisk Inc | 9 | $224 |
| Exact Sciences Corporation | 8 | $147 |
| ABBVIE INC. | 10 | $139 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $136 |
| PFIZER INC. | 6 | $115 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Amgen Inc. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
Products named: Ozempic, XIFAXAN, ZEPBOUND, VRAYLAR, MOUNJARO, JARDIANCE, The Cologuard Plus Collection Kit, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
